Rwe (RWE.DE) traded up 1.94 % during a 24 hours period ending at 12:35 PM Central Europe on Tuesday 27th. One Rwe stock can currently be bought for about EUR 56.73 on popular exchanges. Current supply of Rwe stocks is 710.8 mn. Rwe has a current market capitalization of EUR 40.1 bn and approximately EUR 74.6 mn worth of Rwe was traded on exchanges in the last 24 hours. Since last month end, Rwe has traded -4.13 % down. Simple moving average of last 200 days is at EUR 56.61. The highest price of past 52 weeks was recorded at EUR 62 on 04/30/2026. 52 weeks low was at EUR 40.92 on 10/29/2025.

Summary of the latest news for Rwe

RWE Aktiengesellschaft’s share price has recently slipped, breaking through a short‑term uptrend while remaining within a broader green support zone. Analysts note that the stock’s stability—once regarded as a leading DAX performer—has weakened, raising concerns about potential further declines if the central support level is tested. In parallel, RWE disclosed a series of employee share purchases under its German employee share programme, with a total of 165,000 shares acquired between early October and 23 October 2026. These transactions were executed exclusively via the stock exchange by a credit institution commissioned by the company. The share buyback programme continues to be reported as part of the company’s regulatory disclosures. The broader market saw the DAX opening higher, with RWE among the gainers, reflecting modest overall market strength.

Here is how related stocks have performed in the past 24 hours:

  • Bayerische Motoren Werke (BMW.DE) traded up 0.56 % and now trades at EUR 56.98. Bayerische Motoren Werke has a market capitalisation of EUR 34.8 bn. Current price/earnings ratio for Bayerische Motoren Werke is 5.53. Bayerische Motoren Werke AG announced a continuation of its share‑buyback programme for 2025‑2027, purchasing 106,701 ordinary shares between 19 and 25 October 2026. The transactions were carried out on the Xetra trading floor at an average price that moved gradually within the period. The company’s investor‑relations office confirmed the purchases and provided a link to the detailed transaction list on its website. No further commentary on the impact of the buyback was given.

  • Talanx (TLX.DE) traded up 0.56 % and now trades at EUR 125.9. Talanx has a market capitalisation of EUR 32.6 bn. Current price/earnings ratio for Talanx is 12.52. In recent analysis by the German comparison portal Verivox, the automotive insurance market in Germany has experienced a shift after a period of steep price increases. While premiums for new policies have risen modestly compared to the previous year, the increase remains below the broader inflation trend. The most noticeable changes appear in the mid‑tier segment, where liability coverage costs have edged higher, whereas cheaper providers offer slightly lower rates. In contrast, the lowest‑priced brackets have seen a small decline in costs, particularly for comprehensive coverage. Verivox’s spokesperson emphasized that a permanent price reversal is unlikely, citing ongoing rises in repair and parts costs as key drivers. The data refer exclusively to newly issued policies and exclude existing contracts that have also become more expensive. The overall picture suggests that insurers are still navigating a challenging cost environment, but recent developments point toward a moderation of the upward pressure on premiums.

  • Basf (BAS.DE) traded down -0.4 % and now trades at EUR 51.7. Basf has a market capitalisation of EUR 45 bn. Basf has a current price to earnings ratio of 22.08. BASF SE has continued its share‑buyback programme, purchasing roughly 7.2 million shares between 3 August and 23 October 2026, with daily volumes and average prices disclosed in a regulatory filing. The programme, executed through Xetra and other trading platforms, reflects the company’s ongoing commitment to returning capital to shareholders while maintaining liquidity. No significant operational or strategic developments were reported for BASF during this period. The share‑buyback activity coincides with a broader European market environment characterised by modest gains, stable inflation expectations, and a cautious outlook on corporate earnings.

  • Bayer (BAYN.DE) traded up 3.59 % and now trades at EUR 45.01. Current market capitalisation for Bayer is EUR 44.7 bn. Bayer AG’s recent developments have attracted market attention. In Ohio, the company is investing in a new pharmaceutical facility, signalling continued focus on expanding its manufacturing footprint. Clinical progress for key products also underpins investor interest. A post‑hoc analysis of patient‑reported sleep outcomes for Lynkuet® (elinzanetant) in women with moderate‑to‑severe vasomotor symptoms was presented at the 2026 Menopause Society Annual Meeting, adding to the company’s portfolio of treatments for menopausal symptoms. Meanwhile, a Phase‑III study of the prostate‑cancer drug Nubeqa reported a significant reduction in metastasis and mortality risk, providing a potential new growth driver for the company’s oncology division. These combined investment and clinical updates contribute to a cautiously positive outlook for Bayer’s future performance.

  • Dr Ing Hc F Porsche (P911.DE) traded down -0.65 % and now trades at EUR 43.22. Dr Ing Hc F Porsche has a market capitalisation of EUR 37.9 bn. Current price/earnings ratio for Dr Ing Hc F Porsche is 46.13. Dr. Ing. h.c. F. Porsche AG reported that its first nine months of 2026 show a clear turnaround compared with the previous year. Sales revenue fell, but the operating margin rose sharply, driven in part by a higher share of premium models and favorable pricing and mix effects. Cash flow from the automotive segment strengthened, with net cash flow reaching a high level that supports the company’s liquidity. The sale of stakes in Bugatti Rimac and the Rimac Group contributed to a significant inflow of funds, while one‑off costs related to strategic realignment and pension obligations moderated the cash‑flow increase. The group confirmed its full‑year outlook, expecting a sales volume in the mid‑30 billion‑euro range and an operating margin that will settle between 5½ % and 7½ %. The strategy continues to focus on core products, cost discipline and a value‑over‑volume sales approach, with an eye on expanding the sports‑car identity through new concepts such as the “Sportwagen‑Schmiede 35” and the Mission S vision model.

About Rwe

RWE Aktiengesellschaft is a globally active energy company generating and trading electricity. The company has a capacity of approximately 10 gigawatts based on renewable sources, as well as a gas fleet and an internationally active energy trading business. RWE serves clients in Europe, Asia-Pacific, and the United States. You can find more information about this company and its activities on their website at www.rwe.com . The company’s stock is traded on Xetra.